Zinbryta approved to treat relapsing forms of MS; only one monthly injection required. Read More »

Initial five stops on the tour announced; second consecutive summer tour to train pharmacists in point-of-care testing. Read More »

The interactive forum brings independent pharmacists together to collaborate on ways to expand business, improve profits and help their patients. Read More »

Webinar compliments NACDS efforts in Puerto Rico to encourage women to discuss the zika virus with their health care providers and pharmacists. Read More »

Expanded exclusion lists also could impact pharmacies, patients. Read More »

Sanofi announced this week that the Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) of the Food and Drug Administration (FDA) has recommended the approval of a new drug application from the company. Read More »

The Committee for Medicinal Products for Human Use (CHMP) within the European Medicines Agency has recommended the approval of saxa/dapa for use in treating type-2 diabetes. Read More »

Incyte Corp. announced that approximately 20 abstracts associated with its clinical developments will be presented at the American Society of Clinical Oncology (ASCO) and the European Hematology Association (EHA) meetings in 2016. Read More »

The American Society of Health-System Pharmacists (ASHP) had representatives at a White House meeting regarding opioid abuse this week. Read More »

The U.S. Food and Drug Administration (FDA) announced that it has approved a buprenorphine implant for the treatment of opioid dependence this week. Read More »

CVS Health announced the launch of a digital tool that will allow patients to view wait times at MinuteClinic locations, which is expected to include CVS locations in Target stores later in 2016. Read More »

The Daiichi Sankyo Co. announced this week that it will be joining Takeda Pharmaceutical Limited and Astellas Pharma Inc. in researching the development of a biomarker database. Read More »

The Food and Drug Administration (FDA) has accepted a new drug application (NDA) from Allergan for a cream to treat symptoms of rosacea in adults, the company announced this week. Read More »

Walgreens Boots Alliance Inc. (WBA) announced this week that Barry Rosenstein has stepped down from the company’s board of directors. Read More »

CVS Health announced this week that it will be expanding access to naloxone, a drug used to reverse an opioid overdose, to seven additional states this summer. Read More »

AstraZeneca completed the acquisition of Takeda's core respiratory business recently. Read More »

NRLS allows health clinicians to locate patient records no matter where they were previously treated. Read More »

Outlines steps to reduce opioid use and treat substance abuse as a chronic disease. Read More »

New safety and efficiency data included on labels after EAGLES clinical trial. Read More »

ExtraCare Rewards members can select digital receipts for in-store purchases. Read More »